/ALECR.PA
ALECR.PA Stock - Eurofins-Cerep S.A.
Healthcare|Medical - Diagnostics & ResearchPAR
$17800.00+0.00%
+$0.00 (+0.00%) • Dec 16
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.54
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $19580.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ALECR.PA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$17622.00 – $17978.00
TARGET (TP)$20470.00
STOP LOSS$16376.00
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.17
52W High$20600.00
52W Low$15800.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $40.46M | $44.07M | $47.63M | $41.62M | $32.67M |
| Gross Profit | $17.45M | $20.21M | $23.62M | $20.83M | $15.84M |
| Gross Margin | 43.1% | 45.9% | 49.6% | 50.0% | 48.5% |
| Operating Income | $4.50M | $6.46M | $11.48M | $10.13M | $5.54M |
| Net Income | $7.15M | $7.64M | $11.52M | $9.84M | $5.58M |
| Net Margin | 17.7% | 17.3% | 24.2% | 23.7% | 17.1% |
| EPS | $1418.43 | $1514.43 | $2284.78 | $1951.38 | $1105.73 |
Company Overview
Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company was formerly known as Cerep SA and changed its name to Eurofins Cerep SA in June 2014. Eurofins Cerep SA was founded in 1989 and is based in Vienne, France.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ALECR.PABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$860.74
Q4 2024
EPS Surprise History
Q2 21
No data
Q4 21
No data
Q2 22
No data
Q4 22
No data
Q2 23
No data
Q4 23
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Dec 31, 2024 | — | $860.74 | — | — |
Q3 2024 | Aug 9, 2024 | — | $557.69 | — | — |
Q4 2023 | Dec 30, 2023 | — | $880.40 | — | — |
Q2 2023 | Jun 30, 2023 | — | $634.02 | — | — |
Q4 2022 | Dec 31, 2022 | — | $1192.39 | — | — |
Q2 2022 | Jun 30, 2022 | — | $1092.39 | — | — |
Q4 2021 | Dec 31, 2021 | — | $1051.11 | — | — |
Q2 2021 | Jun 30, 2021 | — | $900.28 | — | — |
Q4 2020 | Dec 31, 2020 | — | $588.88 | — | — |
Q2 2020 | Jun 30, 2020 | — | $516.85 | — | — |
Q4 2019 | Dec 31, 2019 | — | $657.08 | — | — |
Q2 2019 | Jun 30, 2019 | — | $209.36 | — | — |
Q4 2018 | Dec 31, 2018 | — | $348.64 | — | — |
Q2 2018 | Jun 30, 2018 | — | $292.56 | — | — |
Q4 2017 | Dec 31, 2017 | — | $220.40 | — | — |
Q2 2017 | Jun 30, 2017 | — | $479.29 | — | — |
Q4 2016 | Dec 31, 2016 | — | $130.39 | — | — |
Q2 2016 | Jun 30, 2016 | — | $370.54 | — | — |
Q2 2016 | Apr 25, 2016 | — | $301.04 | — | — |
Q4 2015 | Oct 28, 2015 | — | $81.14 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ALECR.PA
What is ALECR.PA's current stock price?
Eurofins-Cerep S.A. (ALECR.PA) is currently trading at $17800.00 per share. The stock has moved +0.00% today.
What is the analyst price target for ALECR.PA?
No analyst price targets are currently available for this stock.
What sector is Eurofins-Cerep S.A. in?
Eurofins-Cerep S.A. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the PAR exchange.
What is ALECR.PA's market cap?
Eurofins-Cerep S.A. has a market capitalization of $0.09 billion, making it a small-cap company.
Does ALECR.PA pay dividends?
No, Eurofins-Cerep S.A. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAB.PA
AB Science S.A.
$1.38
Mkt Cap: $0.1B
AFME.PA
Affluent Medical S.A.
$2.07
Mkt Cap: $0.1B
ALBIO.PA
Biosynex S.A.
$0.58
Mkt Cap: $0.0B
ALCJ.PA
Crossject S.A.
$2.13
Mkt Cap: $0.1B
ALGAE.PA
Fermentalg
$0.41
Mkt Cap: $0.0B
ALKLH.PA
Klea Holding
$0.23
Mkt Cap: $0.1B
ALMDT.PA
Median Technologies S.A.
$4.42
Mkt Cap: $0.2B
ALPRE.PA
Predilife S.A.
$3.30
Mkt Cap: $0.0B
ALSEN.PA
Sensorion S.A.
$0.33
Mkt Cap: $0.1B
MAAT.PA
MaaT Pharma S.A.
$4.12
Mkt Cap: $0.1B
Explore stocks similar to ALECR.PA for comparison